Inactive Instrument
Cellivery Therapeutics, Inc. Share Price
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 4L | |
| +0.13% | -1.33% | +63.86% | +121.93% | 5.58TCr | |
| +6.76% | +18.10% | +91.66% | +104.09% | 5.57TCr | |
| +3.33% | +4.51% | -11.68% | -11.91% | 2.38TCr | |
| +1.32% | +6.22% | +5.28% | +415.45% | 2.27TCr | |
| +0.97% | +3.81% | +31.23% | -32.21% | 1.61TCr | |
| -0.89% | +5.71% | +24.30% | +186.29% | 1.36TCr | |
| +9.96% | +15.98% | +157.65% | +310.89% | 1.48TCr | |
| +2.85% | +2.81% | +75.32% | +139.44% | 1.22TCr | |
| +6.17% | +10.22% | +163.15% | +166.44% | 1.18TCr | |
| Average | +0.02% | +7.40% | +66.75% | +155.60% | 2.52TCr | |
| Weighted average by Cap. | +3.32% | +7.70% | +64.10% | +141.39% |
Employees
4
